Olr750 inhibitors are a class of chemical compounds known for their specific interaction with the olfactory receptor 750 (Olr750), which is part of the extensive family of G-protein-coupled receptors (GPCRs). These inhibitors typically function by binding to the Olr750 receptor, which is predominantly involved in the detection of odor molecules. This receptor is a critical component in the olfactory signaling pathway, where it plays a significant role in the transduction of chemical signals from odorants into electrical signals that can be processed by the brain. The binding of inhibitors to Olr750 can alter the receptor's conformation, thereby modulating its ability to interact with its natural ligands. This modulation can lead to a variety of effects on the signaling pathways that depend on this receptor, potentially affecting the perception of specific odors.
Chemically, Olr750 inhibitors can vary widely in structure, reflecting the diversity of small molecules that can interact with GPCRs. These compounds are often characterized by their ability to form specific non-covalent interactions, such as hydrogen bonds, van der Waals forces, and hydrophobic interactions, with the amino acid residues of the receptor. Structural studies and computational modeling are frequently employed to understand the binding dynamics and affinity of these inhibitors. Additionally, the synthesis and optimization of Olr750 inhibitors often involve iterative processes of chemical modification and bioassay testing to enhance their specificity and potency. These inhibitors are invaluable tools in the field of olfactory research, providing insights into the molecular mechanisms of odor detection and the broader functions of olfactory receptors in various biological systems. Through the detailed study of Olr750 inhibitors, researchers can better understand the intricate processes underlying olfactory signal transduction and receptor-ligand interactions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BIBF1120 | 656247-17-5 | sc-364433 sc-364433A | 5 mg 10 mg | $184.00 $321.00 | 2 | |
Inhibitor of VEGFR, PDGFR, and FGFR, potentially disrupting angiogenesis-related proteins. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $130.00 $182.00 | 2 | |
Multi-kinase inhibitor, potentially affecting proteins in VEGF and PDGF signaling pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, potentially impacting protein degradation pathways and cell cycle regulation. | ||||||
Lenvatinib | 417716-92-8 | sc-488530 sc-488530A sc-488530B | 5 mg 25 mg 100 mg | $182.00 $661.00 $1690.00 | 3 | |
Multi-kinase inhibitor, potentially disrupting proteins in VEGF and FGF signaling pathways. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Proteasome inhibitor, potentially affecting protein degradation and cell cycle regulation. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $245.00 $1051.00 | 7 | |
Androgen receptor inhibitor, potentially affecting proteins in androgen signaling pathways. | ||||||
Regorafenib | 755037-03-7 | sc-477163 sc-477163A | 25 mg 50 mg | $320.00 $430.00 | 3 | |
Multi-kinase inhibitor, potentially impacting proteins in VEGF, PDGF, and FGFR signaling pathways. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Proteasome inhibitor, potentially disrupting protein degradation and cell cycle regulation proteins. | ||||||
Apalutamide | 956104-40-8 | sc-507442 | 5 mg | $290.00 | ||
Androgen receptor inhibitor, potentially affecting proteins in androgen signaling pathways. | ||||||